204 related articles for article (PubMed ID: 32623395)
1. Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
Shi Y; Zhang L; Gao X; Zhang J; Ben Abou M; Liang G; Meng Q; Hepner A; Eckenhoff MF; Wei H
J Alzheimers Dis; 2020; 76(4):1375-1389. PubMed ID: 32623395
[TBL] [Abstract][Full Text] [Related]
2. Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.
Wu Z; Yang B; Liu C; Liang G; Eckenhoff MF; Liu W; Pickup S; Meng Q; Tian Y; Li S; Wei H
Alzheimer Dis Assoc Disord; 2015; 29(3):184-191. PubMed ID: 25650693
[TBL] [Abstract][Full Text] [Related]
3. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
J Alzheimers Dis; 2024; 98(2):549-562. PubMed ID: 38393915
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic intranasal dantrolene on nasal mucosa morphology in mice.
Jiang B; Shi Y; Abou MB; Xu L; Liang G; Wei H
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):198-203. PubMed ID: 35048995
[TBL] [Abstract][Full Text] [Related]
5. Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.
Peng J; Liang G; Inan S; Wu Z; Joseph DJ; Meng Q; Peng Y; Eckenhoff MF; Wei H
Neurosci Lett; 2012 May; 516(2):274-9. PubMed ID: 22516463
[TBL] [Abstract][Full Text] [Related]
6. Intranasal insulin treatment ameliorates spatial memory, muscular strength, and frailty deficits in 5xFAD mice.
Gendron WH; Fertan E; Roddick KM; Wong AA; Maliougina M; Hiani YE; Anini Y; Brown RE
Physiol Behav; 2024 Jul; 281():114583. PubMed ID: 38750806
[TBL] [Abstract][Full Text] [Related]
7. Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Torika N; Asraf K; Cohen H; Fleisher-Berkovich S
Brain Behav Immun; 2017 Aug; 64():80-90. PubMed ID: 28385651
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.
Mast N; Saadane A; Valencia-Olvera A; Constans J; Maxfield E; Arakawa H; Li Y; Landreth G; Pikuleva IA
Neuropharmacology; 2017 Sep; 123():465-476. PubMed ID: 28655608
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatments with a 5-HT
Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
[TBL] [Abstract][Full Text] [Related]
11. Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
Res Sq; 2023 May; ():. PubMed ID: 37214948
[TBL] [Abstract][Full Text] [Related]
12. Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.
Gourmaud S; Thomas P; Thomasseau S; Tible M; Abadie C; Paquet C; Hugon J
J Alzheimers Dis; 2018; 63(2):665-674. PubMed ID: 29660941
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.
Korkmaz OT; Ay H; Aytan N; Carreras I; Kowall NW; Dedeoglu A; Tuncel N
J Mol Neurosci; 2019 Jul; 68(3):389-396. PubMed ID: 30498985
[TBL] [Abstract][Full Text] [Related]
14. Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type mice.
Endres K; Reinhardt S; Geladaris A; Knies J; Grimm M; Hartmann T; Schmitt U
BMC Neurosci; 2016 Jul; 17(1):44. PubMed ID: 27377996
[TBL] [Abstract][Full Text] [Related]
15. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
16. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer's disease.
Chavoshinezhad S; Mohseni Kouchesfahani H; Salehi MS; Pandamooz S; Ahmadiani A; Dargahi L
Brain Res Bull; 2019 Aug; 150():297-306. PubMed ID: 31233762
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer's Disease.
Maiti P; Manna J; Burch ZN; Flaherty DB; Larkin JD; Dunbar GL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933008
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms.
Sarroca S; Gatius A; Rodríguez-Farré E; Vilchez D; Pallàs M; Griñán-Ferré C; Sanfeliu C; Corpas R
J Nutr Biochem; 2021 Mar; 89():108569. PubMed ID: 33321185
[TBL] [Abstract][Full Text] [Related]
19. Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease.
Abou MB; Sun L; Wei H
Curr Alzheimer Res; 2020; 17(4):324-328. PubMed ID: 32442084
[TBL] [Abstract][Full Text] [Related]
20. Myelin changes at the early stage of 5XFAD mice.
Gu L; Wu D; Tang X; Qi X; Li X; Bai F; Chen X; Ren Q; Zhang Z
Brain Res Bull; 2018 Mar; 137():285-293. PubMed ID: 29288735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
